AI assistant
HERBALIFE LTD. — Director's Dealing 2024
Feb 21, 2024
32337_dirs_2024-02-21_229ab8d2-a5b0-4287-b261-780b2a93fa89.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2024-02-16
Reporting Person: JOHNSON MICHAEL (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-16 | Common Stock | P | 61725 | $8.0729 | Acquired | 603707 | Direct |
| 2024-02-16 | Common Stock | A | 495662 | — | Acquired | 1099369 | Direct |
| 2024-02-16 | Common Stock | A | 84839 | — | Acquired | 1184208 | Direct |
| 2024-02-16 | Common Stock | F | 30351 | $8.07 | Disposed | 1153857 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-16 | Stock Appreciation Rights | $8.07 | A | 982800 | Acquired | 2034-02-16 | Common Stock (982800) | Direct |
Footnotes
F1: This transaction represents multiple open market purchases. The range of prices for such transactions is $7.84 to $8.20. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price.
F2: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Issuer's Board of Directors (the "Board"), subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the RSU vest prior to February 16, 2025.
F3: Consists of RSUs fully vested at the time of grant.
F4: Represents shares withheld to satisfy tax obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 16, 2024.
F5: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Board, subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the SAR vest prior to February 16, 2025.